ArticlePharmacoEconomics2024

Different Models, Same Results: Considerations When Choosing Between Approaches to Model Cost Effectiveness of Chimeric-Antigen Receptor T-Cell Therapy Versus Standard of Care.

Amy Gye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.